Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News


morningstar.com > news > pr-newswire > 20/26/0909ny43229 > levi-korsinsky-reminds-regeneron-pharmaceuticals-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-14-2026-regn

Levi & Korsinsky Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN

5+ day, 20+ min ago   (518+ words) NEW YORK, Sept. 9, 2026 Institutional investors with REGN positions may need to assess alleged clinical-trial...Institutional holders often evaluate securities claims through documentation, governance, and loss-size..."Institutional investors play a critical role in securities class actions....INSTITUTIONAL INVESTOR REPRESENTATION — Levi & Korsinsky,…...


scanx.trade > stock-market-news > companies > lincoln-pharmaceuticals-sets-september-30-agm-record-date > 49542405

Lincoln Pharma sets September 11 record date for 32nd AGM

2+ week, 2+ day ago   (534+ words) Lincoln Pharmaceuticals has announced the record date for its 32nd Annual General Meeting. The company will hold the meeting on September 30, 2026, via video conferencing or other audio-visual means. The record date is set for Friday, September 11, 2026. The book closure period runs…...

Web

External web results are waiting for the human check. Complete the press-and-hold control above. Google advertising and AI choices remain separate after verification.